Latest Amferia News & Updates

See the latest news and media coverage for Amferia. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Amferia

Antimicrobial peptide technology developer

amferia.com
Headquarters
Mölndal, Sweden
Founded year
2018
Company type
Private company
Number of employees
2–20

Last updated

Latest news about Amferia

In short: Amferia received FDA De Novo approval for its antibacterial wound dressing and expanded its veterinary distribution network across Europe.

Company announcements

  • Amferia

    Amferia seeks partners post-FDA De Novo approval

    The approval creates a new category for its peptide-based antibacterial wound dressing. Amferia attends EWMA Congress to discuss U.S. market expansion.

  • Amferia

    Amferia signs distribution contract with Interchem for Ireland

    The partnership introduces AMP Wound Dressing to Irish veterinary professionals in Spring 2026, expanding Amferia's European presence.

  • Amferia

    Amferia gains recognition as top wound care company

    Featured in SmartTRAK article on antimicrobial wound care future. Recent FDA De Novo approval highlighted.

  • Amferia

    FDA grants Amferia De Novo approval for antibacterial wound dressing

    The approval creates a new Class 2 category for peptide-based dressings that kill 99.99% of bacteria, including resistant strains, without leaching.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Amferia

Track Amferia and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.